APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS
NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™) ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) —
OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office
London, UK, July 24, 2023 (GLOBE NEWSWIRE) — OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, today announced a new team of experts
Ai-Media Introduces LEXI Viewer: Revolutionizing Live Events with Cutting-Edge Captioning Solution
LEXI Viewer BROOKLYN, N.Y., July 19, 2023 (GLOBE NEWSWIRE) — Ai-Media, the industry leader in technology-driven live captioning, transcription, and translation solutions, is delighted to unveil the ground-breaking LEXI Viewer.
Employers Turn to Business School Grads for Skills of Today and Tomorrow
GMAC survey identifies in-demand talents and hiring projections from corporate recruiters RESTON, Va., July 19, 2023 (GLOBE NEWSWIRE) — Despite unfavorable macroeconomic conditions and looming uncertainties, employers remain confident in
Quantexa Recognized as a Technology Standout in Celent’s 2023 xCelent AML Transaction Monitoring Report
Quantexa’s Decision Intelligence Platform and Financial Crime solutions credited for driving efficiencies through automation and enriching graph analytics and network analysis LONDON and NEW YORK, July 19, 2023 (GLOBE NEWSWIRE)